In contrast, the epidermis of At-Risk individuals with high IFN score A in blood was also characterized by diffuse expression of IFNK, although unlike SLE patients, there were no clinical or histopathological features of inflammation (Fig. 7g). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.